CXCL9/MIG ELISA DY492-05 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemCXCL9/MIG ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $450.00Supplier Page View Company Product Page
Catalog NumberDY492-05
Quantity1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))
ApplicationsELISA
Detection Range15.60 - 1000 pg/mL
ReactivityMouse
Detection TargetCXCL9/MIG
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameC-X-C motif chemokine ligand 9
NCBI Gene AliasesCMK, Humig, MIG, SCYB9, crg-10

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Antigen-specific tolerance and control of autoimmunity effected by liver sinusoidal endothelial cells is unimpaired in liver fibrosisFront ImmunolMay 5, 2026Cornelia Gottwick, Pia Averhoff, Christian Casar, Laura Anne Liebig, Sabrina Melanie Pilz, Victor Haas, Daria Krzikalla, Sabine Fleischer, Norbert Hübner, Lorenz Adlung, et al.Kit,Catalog Nr,Company Elisa Mouse CXCL9/MIG DuoSet,DY492-05,R&D Systems Elisa Mouse IL-6 DuoSet,DY406-05,R&D Systems Foxp3 Staining Buffer Set,00-5523-00,Applied Biosystems

(2) Selective JAK Inhibition Reveals Paradoxical and Hierarchical Control of interferon-γ-driven Autoimmunity in AIRE DeficiencybioRxivMarch 12, 2026Eliezer Heller, Lucas dos Santos Dias, Michail S. LionakisProtease Inhibitor Cocktail (catalog no. 11836170001; Roche, USA). A DuoSet® ELISA kit (catalog no. DY492–05; R&D Systems, USA) was used to measure CXCL9 and a high-sensitivity ELISA kit was used for IFN-γ (catalog

(3) Combination of SH003 and paclitaxel modulates tumor microenvironment and inhibits metastasis of metastatic melanomaMedical OncologyNovember 18, 2025Sang-Eun Lee, Min-Woo Kim, Yun-Beom Sim, Chunhoo Cheon, Seong-Gyu KoSupernatants were collected and stored at −80 °C until analysis. IFN-γ (cat.no. DY485-05), CXCL9 (cat.no. DY492-05), and CXCL10 (cat.no. DY466-05) production levels were quantified using a DuoSet ELISA Kit (R&D Systems,

(4) Poly I:C vaccination drives transient CXCL9 expression near B cell follicles in the lymph node through type-I and type-II interferon signalingCytokineNovember 1, 2024Ball AG, Morgaenko K, Anbaei P, Ewald SE, Pompano RR.analyzed for secreted CXCL9 and CXCL10 by a sandwich ELISA using R&D Systems ELISA kits for CXCL9 (DY492–05) and CXCL10 (DY466–05). In some cases, the samples were also analyzed for secreted IFNα and IFNγ as

(5) TBK1 and IKKε protect target cells from IFNγ-mediated T cell killing via an inflammatory apoptotic mechanismbioRxiv : the preprint server for biologyAugust 8, 2024Sun ND, Carr AR, Krogman EN, Chawla Y, Zhong J, Guttormson MC, Chan M, Hsu MA, Dong H, Bogunovic D, et al.IFNγ (BioLegend, 430801), mouse MCP-1 (CCL2) (BioLegend, 432704), and mouse MIG (CXCL9) (Bio-Techne, DY492–05). RNA isolation and RT-qPCR Cells were seeded in 6-well plates and cultured overnight at 37°C. They

(6) Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in miceEMBO ReportsJuly 26, 2024Anna Macht, Yiqi Huang, Line S Reinert, Vincent Grass, Kristin Lohmer, Elke Tatjana Aristizabal Prada, Eveline Babel, Alexandra Semmler, Wen Zhang, Andrea Wegner, et al.according to the manufacturer’s instructions for CXCL9 (Mouse CXCL9/MIG DuoSet ELISA; R&D Systems; DY492-05) and CXCL10 (Mouse CXCL10/IP-10/CRG-2 DuoSet ELISA; R&D Systems; DY466). Deviations to the protocol

(7) Structural properties of immune complexes formed by viral antigens and specific antibodies shape the inflammatory response of macrophagesCell & BioscienceApril 25, 2024Asta Lučiūnaitė, Kristina Mašalaitė, Ieva Plikusiene, Vincentas Maciulis, Silvija Juciute, Milda Norkienė, Aurelija ŽvirblienėCarlRoth (Germany). Uncoated DuoSet ELISA kits for mouse CXCL2 (#DY452-05), CXCL1 (#DY453-05), CXCL9 (#DY492-05), CXCL16 (#DY503) and CCL8 (#DY790), Proteome Profiler Mouse Chemokine Array Kit (#ARY020) were from

(8) Reduction of chemokine CXCL9 expression by omega-3 fatty acids via ADP-ribosylhydrolase ARH3 in MIN6 insulin-producing cellsbioRxiv : the preprint server for biologyJanuary 31, 2024You Y, Sarkar S, Deiter C, Elliott EC, Nicora CD, Mirmira RG, Sussel L, Nakayasu ES.

(9) A novel aptamer-based small RNA delivery platform and its application to cancer therapyGenes & diseasesMay 1, 2023Tanno T, Zhang P, Bailey C, Wang Y, Ittiprasert W, Devenport M, Zheng P, Liu Y.

(10) Ionizing Radiation Selectively Increases CXC Ligand 10 Level via the DNA-Damage-Induced p38 MAPK-STAT1 Pathway in Murine J774A.1 MacrophagesCellsMarch 25, 2023Seo YN, Baik JS, Lee SM, Lee JE, Ahn HR, Lim MS, Park MT, Kim SD.

(11) Type I IFN stimulates lymph node stromal cells from adult and old mice during a West Nile virus infectionbioRxiv : the preprint server for biologyJanuary 5, 2023Bennett AK, Richner M, Mun MD, Richner JM.

(12) RNAi-based modulation of IFN-γ signaling in skinMolecular therapy : the journal of the American Society of Gene TherapyAugust 3, 2022Tang Q, Sousa J, Echeverria D, Fan X, Hsueh YC, Afshari K, MeHugh N, Cooper DA, Vangjeli L, Monopoli K, et al.assay kit (ThermoFisher Scientific, #23236). Animal studies: Mouse CXCL9 DuoSet ELISA kit (R&D System, #DY492-05) and DuoSet Ancillary Reagent Kit 2 (R&D System, #DY008) were used according to manufacturer’s instructions.

(13) CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancerBritish journal of cancerJune 1, 2022Seitz S, Dreyer TF, Stange C, Steiger K, Bräuer R, Scheutz L, Multhoff G, Weichert W, Kiechle M, Magdolen V, et al.

(14) Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancerJCI insightMay 9, 2022Masuhiro K, Tamiya M, Fujimoto K, Koyama S, Naito Y, Osa A, Hirai T, Suzuki H, Okamoto N, Shiroyama T, et al.

(15) Oxidized carbon black nanoparticles induce endothelial damage through C-X-C chemokine receptor 3-mediated pathwayRedox biologyNovember 1, 2021Majumder N, Velayutham M, Bitounis D, Kodali VK, Hasan Mazumder MH, Amedro J, Khramtsov VV, Erdely A, Nurkiewicz T, Demokritou P, et al.

(16) NK cell recruitment limits tissue damage during an enteric helminth infectionMucosal immunologyMarch 1, 2020Gentile ME, Li Y, Robertson A, Shah K, Fontes G, Kaufmann E, Polese B, Khan N, Parisien M, Munter HM, et al.

(17) LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8⁺ T cell tumor-infiltration impairing anti-PD1 therapyNature communicationsJune 11, 2019Pascual-García M, Bonfill-Teixidor E, Planas-Rigol E, Rubio-Perez C, Iurlaro R, Arias A, Cuartas I, Sala-Hojman A, Escudero L, Martínez-Ricarte F, et al.

(18) In-depth characterization of congenital Zika syndrome in immunocompetent mice: Antibody-dependent enhancement and an antiviral peptide therapyEBioMedicineJune 1, 2019Camargos VN, Foureaux G, Medeiros DC, da Silveira VT, Queiroz-Junior CM, Matosinhos ALB, Figueiredo AFA, Sousa CDF, Moreira TP, Queiroz VF, et al.

(19) The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppressionNature communicationsMarch 9, 2017Ahn R, Sabourin V, Bolt AM, Hébert S, Totten S, De Jay N, Festa MC, Young YK, Im YK, Pawson T, et al.

(20) Regulation of C-X-C chemokine gene expression by keratin 17 and hnRNP K in skin tumor keratinocytesThe Journal of cell biologyMarch 2, 2015Chung BM, Arutyunov A, Ilagan E, Yao N, Wills-Karp M, Coulombe PA.

Be the First to Write a Review!

CXCL9/MIG ELISA

Mouse CXCL9/MIG DuoSet ELISA

CXCL9/MIG ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (29)

Reviews

CXCL9/MIG ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map